Ionis Pharmaceuticals, Inc. (IONS) Operating income 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual operating income history from SEC filings — each fiscal year as reported.
-$381.7MFY2025 · since FY2016: -$20.2M → -$381.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$381.7M | +19.7% |
| FY2024 | -$475.1M | -34.3% |
| FY2023 | -$353.7M | +13.8% |
| FY2022 | -$410.2M | -1258.9% |
| FY2021 | -$30.2M | +82.5% |
| FY2020 | -$172.1M | -147.0% |
| FY2019 | $365.9M | +696.2% |
| FY2018 | -$61.4M | -297.7% |
| FY2017 | $31.0M | +254.0% |
| FY2016 | -$20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Gross marginIONS Operating marginIONS Operating cash flowIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Total liabilitiesIONS Shareholders’ equityIONS overview →